Private equity firms have begun positioning for a sale of Merck KGaA’s Effect Pigments division, sources familiar with the matter said, putting the automotive-exposed unit back on the divestiture pipeline.
GP and Katalist's founders are planning bolt-ons for the food and pharma supply chain software firm
Italian sports technology provider first sale attempt was hampered by the onset of COVID-19 in early 2020
Nick Chronias will lead the firm’s focus on private credit and private infrastructure secondaries
Dörte Höppner joined the GP in 2017 and will be responsible for its ESG initiatives globally